Please login to the form below

Not currently logged in
Email:
Password:

outcomes

This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.

Bayer’s finerenone scores FDA priority review for chronic kidney disease

Bayer’s finerenone scores FDA priority review for chronic kidney disease

On the primary endpoint of kidney failure outcomes, patients treated with finerenone an 18% relative risk reduction compared to the placebo group. ... The key secondary endpoint, which measures cardiovascular outcomes, found that the finerenone treatment

Latest news

More from news
Approximately 14 fully matching, plus 1,827 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 10 fully matching, plus 504 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 64 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 10 fully matching, plus 553 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics